Navigation Links
Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
Date:5/19/2009

MENLO PARK, Calif., May 19 /PRNewswire/ -- Apieron, Inc. (www.apieron.com) significantly strengthened its senior management team with the appointment of Steve Bubrick as Vice President, Sales & Marketing, and Bryan Miller as Vice President, Finance. Both appointments are effective immediately.

Mr. Bubrick has more than 20 years of operational and commercial experience in the consumer medical device industry, mainly in diabetes management. Prior to joining Apieron, Mr. Bubrick was the Vice President of Customer Care & Reimbursement for Bedford, Massachusetts-based Insulet Corp., where he contributed to the company's 170% revenue growth in 2008. Before joining Insulet, Mr. Bubrick was Director, Worldwide Marketing for in-vivo products at Abbott Diabetes Care, which was formed by Abbott's acquisition of TheraSense, at which he was a commercial and R&D director. Prior to TheraSense, Mr. Bubrick held numerous commercial and international roles at LifeScan Inc., a division of Johnson & Johnson. Steve earned his BA at the University of California, Berkeley.

"We see many parallels between the self glucose testing and eNO monitoring markets," said Holly McGarraugh, Apieron CEO. "Steve understands how to grow a start up business like Apieron through great marketing and customer relations. His leadership will play a strategically important role in understanding our markets, serving our customers and driving sales of the Insight eNO System. With Bryan filling a critical financial leadership role, and Steve joining us to focus our commercial efforts, we've significantly increased the depth and experience on the senior management team."

Mr. Miller most recently served as a Principal at Berkshire Financial Management LLC where he handled financial and management consulting and equity management of properties in California, Nevada and Arizona. Prior to that, Mr. Miller was the Senior Director of Finance at eV3, (FoxHollow Technologies, Inc.) the medical device company, where he was responsible for financial planning, forecasting and analysis as well as internal reporting. Mr. Miller has an extensive background in financial leadership roles, having held additional senior positions with Trimble Navigation, Shopping the Globe, Inc. and Sega of America. He earned his MBA at Stanford University Graduate School of Business and his BS at University of California, Los Angeles

About the Insight eNO System

The Insight eNO System has been available for use in the physicians' office since March 2008. The system uses a proprietary biosensor technology to measure exhaled nitric oxide, a well established indicator of asthma severity and steroid responsive airway inflammation. Measuring eNO and determining the level of airway inflammation can help clinicians more closely manage their patients' asthma and therefore more precisely titrate medications, which can lead to fewer asthma exacerbations.

About Apieron Inc.

Apieron Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. Apieron is committed to collaborating with physicians and patients to develop innovative medical solutions to improve quality of life and standards of care.

    Contact:
    Steve DiMattia
    (646) 201-5445


'/>"/>
SOURCE Apieron, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. frog design Strengthens Creative Leadership With New Appointments
2. China YCT International (OTCBB: CYIG) Strengthens Corporate Governance With Establishment of Audit Committee and Appointments of Three New Independent Directors
3. Sparta Systems Strengthens TrackWise(R) Enterprise Class Quality Management Solution with Robust Web Services Capabilities
4. NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase(R)) and Strengthens Clinical Leadership
5. Pharos Innovations Strengthens Leadership Team, Informatics Program
6. LifeSecure Insurance Company Strengthens National Footprint with Partnership Program Approvals in Six States
7. Globus Medical Strengthens Executive Team with Appointment of CFO
8. Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations
9. Study strengthens link between tobacco smoke and behavioral problems in boys with asthma
10. Innerscope Research Strengthens Management Team With Three Executive Appointments
11. New evidence strengthens link between cigarette smoke exposure and poor infant health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: